Fol. Biol. 2013, 59, 99-102
https://doi.org/10.14712/fb2013059020099
Salivary Levels of TNF-α and IL-6 in Patients with Oral Premalignant and Malignant Lesions
References
1. 2011) Oral squamous cell carcinoma, socioeconomic status and history of exposure to alcohol and tobacco. J. Natl. Med. Assoc. 103, 498-502.
, B. F., Olusanya, A. A., Lawoyin, J. O. (
2. 2006) The significance of salivary interleukin 6 and tumour necrosis factor α in patients with oral leukoplakia. Oral. Oncol. 42, 370-373.
< , V., Vučićević-Boras, V., Cekić-Arambašin, A., Alajbeg, I. Z., Milenović, A., Lukač, J. (https://doi.org/10.1016/j.oraloncology.2005.09.001>
3. 1996) A cytokine profile of normal and malignant ovary. Cytokine 8, 578-585.
< , F., Relf, M., Negus, R., Balkwill, F. (https://doi.org/10.1006/cyto.1996.0077>
4. 2003) Oral lichen planus: progress in understanding malignant potential and implications for clinical management. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96, 32-37.
< , J. B., Wan, L. S., Gorsky, M., Zhang, L. (https://doi.org/10.1016/S1079-2104(03)00161-6>
5. 2003) Giant keratoacanthoma arising in hypertrophic lichen planus. Australas. J. Dermatol. 44, 267-269.
< , L. M., Reid, C. M., James, C. L., Huilgol, S. C. (https://doi.org/10.1046/j.1440-0960.2003.00006.x>
6. 2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41, 2502-2512.
< , D. R., Hurt, E. M., Farrar, W. L. (https://doi.org/10.1016/j.ejca.2005.08.016>
7. 2008) Cancer statistic. CA Cancer J. Clin. 58, 71-96.
< , A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M. J. (https://doi.org/10.3322/CA.2007.0010>
8. 2005) Interleukin-6: from basic science to medicine – 40 years in immunology. Annu. Rev. Immunol. 23, 1-21.
< , T. (https://doi.org/10.1146/annurev.immunol.23.021704.115806>
9. 2000) Candidate genes for hypoxic tumour phenotype. Cancer Res. 60, 883-887.
, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., Kooch, C., Evans, S., Ibrahim, H., Le, Q. T., Terris, D. T., Giacca, A. J. (
10. 2008) Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin. Proc. 83, 489-501.
< , S., Forastiere, A. A. (https://doi.org/10.4065/83.4.489>
11. 1993) Methods for collecting saliva. Ann. N Y. Acad. Sci. 20, 72-77.
< , M. (https://doi.org/10.1111/j.1749-6632.1993.tb18343.x>
12. 2010) Prognostic significance of p53 and KAI-1 expression in patients with laryngeal squamous cell carcinoma. Anal. Quant. Cytol. Histol. 32, 247-353.
, M., Magliulo, G., Salvolini, E., Orciani, M., Gioacchini, F. M., Goteri, G., Rubini, C. (
13. 2005a) NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detec. Prev. 29, 42-45.
< , N. L., Ho, V., Miller, C. S., Myers, S., Ondrey, F. (https://doi.org/10.1016/j.cdp.2004.10.003>
14. 2005b) The feasibility of monitoring NF-κB associated cytokines: TNF-α, IL-1α, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol. Carcinog. 44, 77-82.
< , N. L., Cheng, B., Myers, S., Miller, L., Ondery, F. (https://doi.org/10.1002/mc.20113>
15. 2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117, 3988-4002.
< , P., Storci, G., Tavolari, S., Guarnieri, T., Giovanni, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., Bonafe, M. (https://doi.org/10.1172/JCI32533>
16. 2001) Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge. J. Am. Dent. Assoc. 132 (Suppl) 7S-11S.
< , S., Jr. (https://doi.org/10.14219/jada.archive.2001.0382>
17. 2004) Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 130, 929-935.
< , M. A., Li, Y., Zhou, X., Denny, P., Ho, C.M., Montemagno, C., Shi, W., Qi, F., Wu, B., Sinha, U., Jordan, R., Wolinsky, L., Park, N. H., Liu, H., Abemayor, L., Wong, D. T. (https://doi.org/10.1001/archotol.130.8.929>